vs
CORCEPT THERAPEUTICS INC（CORT）与Navios Maritime Partners L.P.（NMM）财务数据对比。点击上方公司名可切换其他公司
Navios Maritime Partners L.P.的季度营收约是CORCEPT THERAPEUTICS INC的1.6倍（$327.6M vs $202.1M），Navios Maritime Partners L.P.净利率更高（21.4% vs 12.0%，领先9.3%），CORCEPT THERAPEUTICS INC同比增速更快（11.1% vs -4.3%）
Corcept Therapeutics是一家制药企业，专注于严重代谢疾病、精神疾病及肿瘤疾病治疗药物的发现、开发与商业化。公司围绕皮质醇过量带来的不良影响展开研究，致力于开发可缓解相关症状的新型化合物，管理团队由首席执行官兼总裁、董事Joseph K. Belanoff医学博士领导。
Navios Maritime Partners L.P.是一家跨国垂直整合的海运及物流企业，核心业务涵盖铁矿石、煤炭、粮食等干散货大宗商品的运输与中转，在全球海运供应链领域具备成熟的运营能力与资源布局。
CORT vs NMM — 直观对比
营收规模更大
NMM
是对方的1.6倍
$202.1M
营收增速更快
CORT
高出15.4%
-4.3%
净利率更高
NMM
高出9.3%
12.0%
损益表 — Q4 FY2025 vs Q2 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $202.1M | $327.6M |
| 净利润 | $24.3M | $69.9M |
| 毛利率 | 98.7% | 90.5% |
| 营业利润率 | 2.2% | — |
| 净利率 | 12.0% | 21.4% |
| 营收同比 | 11.1% | -4.3% |
| 净利润同比 | -21.0% | -31.1% |
| 每股收益（稀释后） | $0.20 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CORTNMM
| Q4 25 | $202.1M | — | ||
| Q3 25 | $207.6M | — | ||
| Q2 25 | $194.4M | $327.6M | ||
| Q1 25 | $157.2M | — | ||
| Q4 24 | $181.9M | — | ||
| Q3 24 | $182.5M | — | ||
| Q2 24 | $163.8M | $342.2M | ||
| Q1 24 | $146.8M | — |
净利润CORTNMM
| Q4 25 | $24.3M | — | ||
| Q3 25 | $19.7M | — | ||
| Q2 25 | $35.1M | $69.9M | ||
| Q1 25 | $20.5M | — | ||
| Q4 24 | $30.7M | — | ||
| Q3 24 | $47.2M | — | ||
| Q2 24 | $35.5M | $101.5M | ||
| Q1 24 | $27.8M | — |
毛利率CORTNMM
| Q4 25 | 98.7% | — | ||
| Q3 25 | 97.8% | — | ||
| Q2 25 | 98.2% | 90.5% | ||
| Q1 25 | 98.5% | — | ||
| Q4 24 | 98.4% | — | ||
| Q3 24 | 98.4% | — | ||
| Q2 24 | 98.5% | 88.3% | ||
| Q1 24 | 98.3% | — |
营业利润率CORTNMM
| Q4 25 | 2.2% | — | ||
| Q3 25 | 4.9% | — | ||
| Q2 25 | 13.7% | — | ||
| Q1 25 | 2.2% | — | ||
| Q4 24 | 13.9% | — | ||
| Q3 24 | 25.5% | — | ||
| Q2 24 | 21.7% | — | ||
| Q1 24 | 20.1% | — |
净利率CORTNMM
| Q4 25 | 12.0% | — | ||
| Q3 25 | 9.5% | — | ||
| Q2 25 | 18.1% | 21.4% | ||
| Q1 25 | 13.1% | — | ||
| Q4 24 | 16.9% | — | ||
| Q3 24 | 25.9% | — | ||
| Q2 24 | 21.7% | 29.7% | ||
| Q1 24 | 18.9% | — |
每股收益（稀释后）CORTNMM
| Q4 25 | $0.20 | — | ||
| Q3 25 | $0.16 | — | ||
| Q2 25 | $0.29 | — | ||
| Q1 25 | $0.17 | — | ||
| Q4 24 | $0.25 | — | ||
| Q3 24 | $0.41 | — | ||
| Q2 24 | $0.32 | — | ||
| Q1 24 | $0.25 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $372.2M | $377.0M |
| 总债务越低越好 | — | $2.0B |
| 股东权益账面价值 | $647.8M | — |
| 总资产 | $836.7M | $5.9B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CORTNMM
| Q4 25 | $372.2M | — | ||
| Q3 25 | $421.7M | — | ||
| Q2 25 | $342.2M | $377.0M | ||
| Q1 25 | $322.8M | — | ||
| Q4 24 | $383.3M | — | ||
| Q3 24 | $380.3M | — | ||
| Q2 24 | $473.2M | $272.0M | ||
| Q1 24 | $410.8M | — |
总债务CORTNMM
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $2.0B | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $1.4B | ||
| Q1 24 | — | — |
股东权益CORTNMM
| Q4 25 | $647.8M | — | ||
| Q3 25 | $631.9M | — | ||
| Q2 25 | $635.8M | — | ||
| Q1 25 | $683.3M | — | ||
| Q4 24 | $679.6M | — | ||
| Q3 24 | $638.8M | — | ||
| Q2 24 | $596.2M | — | ||
| Q1 24 | $547.9M | — |
总资产CORTNMM
| Q4 25 | $836.7M | — | ||
| Q3 25 | $823.6M | — | ||
| Q2 25 | $801.7M | $5.9B | ||
| Q1 25 | $846.5M | — | ||
| Q4 24 | $840.6M | — | ||
| Q3 24 | $784.3M | — | ||
| Q2 24 | $714.6M | $5.3B | ||
| Q1 24 | $655.9M | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $38.4M | — |
| 自由现金流经营现金流 - 资本支出 | $38.4M | — |
| 自由现金流率自由现金流/营收 | 19.0% | — |
| 资本支出强度资本支出/营收 | 0.0% | — |
| 现金转化率经营现金流/净利润 | 1.58× | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流CORTNMM
| Q4 25 | $38.4M | — | ||
| Q3 25 | $54.5M | — | ||
| Q2 25 | $43.9M | — | ||
| Q1 25 | $5.1M | — | ||
| Q4 24 | $59.3M | — | ||
| Q3 24 | $73.8M | — | ||
| Q2 24 | $41.2M | — | ||
| Q1 24 | $23.8M | — |
自由现金流CORTNMM
| Q4 25 | $38.4M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $43.9M | — | ||
| Q1 25 | $5.0M | — | ||
| Q4 24 | $59.2M | — | ||
| Q3 24 | $72.2M | — | ||
| Q2 24 | $40.8M | — | ||
| Q1 24 | — | — |
自由现金流率CORTNMM
| Q4 25 | 19.0% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 22.6% | — | ||
| Q1 25 | 3.2% | — | ||
| Q4 24 | 32.5% | — | ||
| Q3 24 | 39.5% | — | ||
| Q2 24 | 24.9% | — | ||
| Q1 24 | — | — |
资本支出强度CORTNMM
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 0.1% | — | ||
| Q4 24 | 0.1% | — | ||
| Q3 24 | 0.9% | — | ||
| Q2 24 | 0.3% | — | ||
| Q1 24 | 0.0% | — |
现金转化率CORTNMM
| Q4 25 | 1.58× | — | ||
| Q3 25 | 2.77× | — | ||
| Q2 25 | 1.25× | — | ||
| Q1 25 | 0.25× | — | ||
| Q4 24 | 1.93× | — | ||
| Q3 24 | 1.56× | — | ||
| Q2 24 | 1.16× | — | ||
| Q1 24 | 0.86× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
